Clinical Trial

Comparison of the Sensitivity of pCLE and Pathological Biopsy for Gastric Mucosal Lesions

Study acronym: pCLE
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 2, 2026 (before its estimated April 10, 2026 completion). Its status may not reflect the trial's current state.
Summary
The pathological biopsy of gastric lesions, performed prior to endoscopic submucosal dissection (ESD), is crucial for differentiating the pathological nature of the lesions and guiding treatment decisions. However, due to the impact of biopsy sampling, the sensitivity of the pathological biopsy is not optimal. The probe - based confocal laser endomicroscopy (pCLE) technique enables the real - time display of high-resolution microscopic images of the mucosal layer (with an amplification factor of up to 1000 times) through a slender optical fiber probe that can pass through the standard endoscope's working channel. It is an optical biopsy technique and has unique value in determining the pathological nature of gastric lesions. As the Digestive Endoscopy Center of Shanghai Changhai Hospital is a national-level pCLE application demonstration center, it has prospectively collected numerous cases of pCLE examinations of gastric mucosal lesions. The main purpose of this study is to retrospectively analyze these cases and compare the sensitivity and specificity of pathological biopsy and pCLE in differentiating the pathological nature of gastric mucosal lesions.
Trial Details
NCT Number NCT07507071
Lead Sponsor Changhai Hospital
Conditions Early Gastric Cancer
Enrollment 169 participants
Start Date 2026-03-30
Primary Completion 2026-04-10 (estimated)
Study Completion 2026-04-15 (estimated)
Updated on ClinicalTrials.gov 2026-04-02